Rosuvastatin Efficacy in South Asian Patients: Documented Gaps, Dosing, and Pharmacogenomics
South Asian patients metabolize rosuvastatin differently due to ABCG2 and SLCO1B1 polymorphisms, leading to higher plasma exposure at standard doses. Evidence-based dosing considerations and open questions reviewed.